openPR Logo
Press release

BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate

05-08-2023 03:35 PM CET | Health & Medicine

Press release from: BOC Sciences

BOC Sciences, a leading CRO in the USA, unveils its comprehensive capabilities for custom peptide drug conjugate from project design to commercial production. With its well-established conjugation platform, BOC Sciences supports pharmaceutical and biotechnology clients at the forefront of drug conjugation.

Peptide-drug conjugates (PDCs) are mainly used in anti-cancer therapy, which integrates the advantages of small molecular weight, high tumor penetration, low immunogenicity, large-scale synthesis using solid phase synthesis, low production cost, relatively good pharmacokinetics, and so on. Peptides selected for PDCs can specifically target protein receptors overexpressed in tumor tissue and have strong binding affinity for the target site within nanomolar amounts, such as cell-targeting peptides (CTPs) and cell-penetrating peptides (CPPs).

BOC Sciences' comprehensive conjugation platform, coupled with its strong small molecule chemistry capability, provides a one-stop solution for peptide drug conjugate development and manufacturing. The company utilizes its proprietary peptide techniques to identify candidate peptides selected by clients from BOC Sciences' peptide library and optimize hit peptides into therapeutic peptide products. Additionally, from peptide synthesis and modifications to peptide conjugates, the company will ensure substantial purity.

BOC Sciences can produce payloads of PDCs through its advanced technologies including fermentation. With its streamlined fermentation process and extensive expertise, the company is able to give customers GMP-grade products from small to large scale-up. Furthermore, each peptide drug conjugate is meticulously monitored during synthesis and controlled according to its quality assurance and quality control standards. And the final product is identified by NMR and MS as well as X-ray crystallography and the purity is analyzed by HPLC or appropriate analytical methods. Advanced quality assurance procedures are also followed independently to double guarantee the high quality of every delivered product.

"We know PDCs have strong tumor penetration, low production cost, and low immunogenicity. Compared with other drug conjugates, PDCs have a wider industrial base and clinical value. Our conjugation platform and experience allow us to further forge partnerships with customers who depend on our capabilities for the development and commercial production of high-quality peptide drug conjugates." Said the marketing manager at BOC Sciences.

BOC Sciences
New York, 11967, USA
Linna Green
account@bocsci.com

About BOC Sciences
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, characterization, etc. After years of expansion, it has established a series of advanced chemical synthesis laboratories, fermentation facilities, QA systems, and so forth. BOC Sciences offers high-quality products for its esteemed customers in academia, pharmaceuticals, biotech, CDMO, material sciences, and agriculture to support research and production needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate here

News-ID: 3045265 • Views:

More Releases from BOC Sciences

BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Part …
In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands. Innovations in manufacturing processes, more complicated formulations, and increasingly complex global supply chains are just some of the factors making it more difficult for companies to assess and control impurities in drug substances and drug products. BOC Sciences is confident to employ
High-Standard Fermented Raw Materials that Satisfy the Quality Attributes of Hea …
New York, United States-Oct 12, 2022-Managing raw materials as part of the quality system will ensure that all finished healthcare products can meet quality attributes. As a comprehensive supplier of CRO/CMO/CDMO fermentation services, BOC Sciences is able to provide clients with high-standard raw materials to ensure quality attributes of final healthcare products. Some key factors that should be taken into consideration when selecting raw materials for healthcare products include sufficient
Optimal Peptides of BOC Sciences Arouse Heated Discussions at TIDES USA 2022
BOC Sciences successfully participated in TIDES USA 2022 from May 9th to 12th, at Hynes Convention Center, Boston. During the four-day exhibition, experts from BOC Sciences and global visitors are engaged in heated discussions concerning novel advances in peptide and amino acid synthesis, discovery, design, and engineering. BOC Sciences has been preparing for the world's largest gathering of pharmaceutical industry for several months. This year, it attracts a great number
A Collection of Current In-Demand COVID-19 Related Products
As the COVID-19 pandemic keeps spreading around the world with no sign of slowing down, massive research about drugs, vaccines, and other therapies is in full swing to mitigate the negative impact on human well-being. BOC Sciences offers several related products that show great benefits to the anti-epidemic activities. These include SARS-CoV-2 inhibitors and key raw materials for the production of disinfectants, test reagents, and vaccines. SARS-CoV-2 Inhibitors Vaccines are widely recognized as

All 5 Releases


More Releases for PDCs

Creative Peptides Released One-Stop Solution for All Peptide Drug Conjugate Need …
New York, United States-Sep 5, 2022-Peptide drug conjugate (PDC) is emerging as a novel type of conjugate drug, showing advantageous features over antibody-drug conjugates (ADCs). As a dedicated peptide manufacturer, Creative Peptides provides a one-stop solution for all peptide drug bioconjugation needs to help pharmaceutical clients bring more PDCs to the market. Structurally, PDC mainly contains three elements-cytotoxin, linker, and targeted peptide, in which a specific peptide sequence covalently connects with
Global Polymer-derived Ceramics Market To Grow At A CAGR Of 10.2% By 2022| Ceram …
Albany, NY, 3rd May : Recent research and the current scenario as well as future market potential of "Polymer-derived Ceramics: Global Markets Through 2022" globally. The polymer derived ceramics market is projected to have high growth with a CAGR of REDACTED, in terms of value, during the forecast period. Asia-Pacific is projected to be the fastest-growing and largest region. In 2016, Asia-Pacific was a substantial contributor of polymer derived ceramics in
Polymer-derived Ceramics Market Facts, Developments, Growth, Solutions & Applica …
The polymer derived ceramics market is projected to have high growth with a CAGR of REDACTED, in terms of value, during the forecast period. Asia-Pacific is projected to be the fastest-growing and largest region. In 2016, Asia-Pacific was a substantial contributor of polymer derived ceramics in the global market. This is mainly due to the high growth in aerospace, industrial, energy, and semiconductor and electronics industries in the region. The
Global Polymer-derived Ceramics 2019: Markets Through 2022
Press Release – 30 Jan 2019 Research and Development News -- . . Latest Update "Polymer-derived Ceramics: Global Markets Through 2022" with Industries Survey | Global Current Growth and Future. ' ' The polymer derived ceramics market is projected to have high growth with a CAGR of xxx, in terms of value, during the forecast period. Asia-Pacific is projected to be the fastest-growing and largest region. In 2016, Asia-Pacific was a substantial contributor of
Polymer-derived Ceramics Size and Forecast 2025 : CeramTec, COI Ceramics, Inc., …
ResearchMoz include new market research report "Polymer-derived Ceramics: Global Markets Through 2022" to its huge collection of research reports. The polymer derived ceramics market is projected to have high growth with a CAGR of REDACTED, in terms of value, during the forecast period. Asia-Pacific is projected to be the fastest-growing and largest region. In 2016, Asia-Pacific was a substantial contributor of polymer derived ceramics in the global market. This is mainly
Global Polymer-derived Ceramics Market to 2022| CeramTec, COI Ceramics Inc, Japa …
Albany, NY, 17th August : Recent research and the current scenario as well as future market potential of "Polymer-derived Ceramics: Global Markets Through 2022" globally. The polymer derived ceramics market is projected to have high growth with a CAGR of REDACTED, in terms of value, during the forecast period. Asia-Pacific is projected to be the fastest-growing and largest region. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1803594 In 2016, Asia-Pacific was